Lynx Capital Group Ltd
- SEC CIK
- 0001013287
- Latest filing
- Aug 12, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Lynx Capital Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −42,096−100.0% | Sold out | Holders |
| Q4 2025 | 42,096 | $2.14M | 1.0% | −513−1.2% | Reduced | Holders |
| Q3 2025 | 42,609 | $2.36M | 1.1% | +539+1.3% | Added | Holders |
| Q2 2025 | 42,070 | $2.90M | 1.4% | +30,788+272.9% | Added | Holders |
| Q1 2025 | 11,282 | $783.5K | 0.4% | −54−0.5% | Reduced | Holders |
| Q4 2024 | 11,336 | $975.2K | 0.6% | −139−1.2% | Reduced | Holders |
| Q3 2024 | 11,475 | $1.37M | 0.9% | −1,705−12.9% | Reduced | Holders |
| Q2 2024 | 13,180 | $1.88M | 1.3% | −72−0.5% | Reduced | Holders |
| Q1 2024 | 13,252 | $1.70M | 1.1% | −1,760−11.7% | Reduced | Holders |
| Q4 2023 | 15,012 | $1.55M | 1.2% | – | No prior filing | Holders |